Sam Altman, IPO and OpenAI
Digest more
Africa, IPO
Digest more
Sept 14 (Reuters) - Drug developer Electra Therapeutics is targeting a valuation of up to $977.6 million in its U.S. initial public offering, according to a filing on Monday, extending a comeback in biotech listings this year. The South San Francisco ...
As Anthropic meets with prospective investors ahead of its potentially historic market debut, CEO Dario Amodei is pushing for a slowdown in AI.
Anthropic has reportedly selected Nasdaq for its planned initial public offering, according to Reuters, marking another significant step toward what could become one of the largest technology listings ever completed.
Etihad Airways Chief Executive Officer Antonoaldo Neves discusses fuel price hedging and the risks around the conflict in the Middle East. He also talks about a possible future IPO, saying the airline doesn't have any plans for that.
Bamboo's roadshow is expected to price within days. At the $19 midpoint, the 35 million shares on offer would generate roughly $665 million in gross proceeds. All of it goes to CVC and White Mountains, not to Bamboo's balance sheet.
SpaceX raised $75 billion in the largest IPO ever, triggering a capital rotation out of Magnificent 7 stocks as investors rebalance toward
Anthropic PBC has picked Nasdaq as its listing venue ahead of a potential record-setting initial public offering, according to a person familiar with the matter.
Sam Altman says market debut would be ‘ill-advised’ but Anthropic chases a $2 trillion valuation despite calls for AI development pause.
The Claude maker has selected Nasdaq for a potential listing and could seek to raise as much as $100 billion, while its annualized revenue has surged above $65 billion and adjusted operating income is expected to remain positive for a second consecutive quarter.